Target Price | HKD22.55 |
Price | HKD19.20 |
Potential |
17.46%
register free of charge
|
Number of Estimates | 15 |
15 Analysts have issued a price target Sinopharm Group 2026 .
The average Sinopharm Group target price is HKD22.55.
This is
17.46%
register free of charge
HKD27.41
42.79%
register free of charge
HKD16.95
11.72%
register free of charge
|
|
A rating was issued by 18 analysts: 14 Analysts recommend Sinopharm Group to buy, 3 to hold and 1 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Sinopharm Group stock has an average upside potential 2026 of
17.46%
register free of charge
|
Dec '24 |
2025 Estimates |
|
---|---|---|
Revenue Billion HKD | 638.90 | 656.41 |
2.02% | 2.74% | |
EBITDA Margin | 3.35% | 3.40% |
16.88% | 1.35% | |
Net Margin | 1.21% | 1.33% |
20.53% | 10.27% |
17 Analysts have issued a sales forecast Sinopharm Group 2025 . The average Sinopharm Group sales estimate is
This results in the following potential growth metrics:
16 Analysts have issued an Sinopharm Group EBITDA forecast 2025. The average Sinopharm Group EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
7 Sinopharm Group Analysts have issued a net profit forecast 2025. The average Sinopharm Group net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Dec '24 |
2025 Estimates |
|
---|---|---|
Earnings Per Share HKD | 2.47 | 2.81 |
22.08% | 13.77% | |
P/E | 6.84 | |
EV/Sales | 0.13 |
7 Analysts have issued a Sinopharm Group forecast for earnings per share. The average Sinopharm Group EPS is
This results in the following potential growth metrics and future valuations:
Sinopharm Group...
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.